Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,167

A new study led by UCL researchers has identified patterns in how common health conditions occur together in the same individuals, using data from 4 million patients in England.

With advancing age, millions of people live with multiple conditions—sometimes referred to as multimorbidity—and the proportion of people affected in this way is expected to rise over the next decades. However, and training, , clinical guidelines and research have evolved to focus on one disease at a time.

The Academy of Medical Sciences and the UK Chief Medical Officer (CMO) have recognized this problem and set out a challenge of investigating which diseases co-occur in the same individuals and why.

Read more | >

Anne Austin/University of Missouri-St. Louis, The Journal of Egyptian Archaeology (2022).

Because the second mummy was still wrapped, researchers analyzed it via infrared photography. It’s worth noting that archaeologists do not unwrap mummies at this point in time. The mummy turned out to be of a middle-aged woman and featured a different tattoo — a wedjat, or eye of Horus, and again an image of the god Bes, but now with a crown of feathers. The scientists also spotted a zigzag line below the other figures that probably depicted a marsh, which was associated with cooling waters used to relieve pain from menstruation or childbirth, as the researchers deduced from ancient medical texts. They propose that the two tattoos were essentially a request by the wearer for protection during childbirth.

Read more | >

If your morning never starts without a cup of coffee, you may be intrigued to learn that drinking the wildly popular beverage could significantly lower your risk of dying within the next few years, a new study suggests.

The study, published online May 31, 2022, by Annals of Internal Medicine, analyzed data about coffee consumption from more than 170,000 people (average age 56) from the United Kingdom who did not have cancer or cardiovascular disease at the study’s start. The researchers tracked participants over an average of seven years. They also accounted for such factors as lifestyle, diet, sex, age, and ethnicity.

People who drank 1.5 to 3.5 cups of coffee each day, even with a teaspoon of added sugar per cup, were up to 30% less likely to die during the study period than those who didn’t drink coffee. It didn’t appear to matter if the coffee contained caffeine or not, but the benefit tapered off for those drinking more than 4.5 cups each day.

Read more | >

The only time might be willing to take shit off someone.

— Cancer patients weren’t responding to therapy. Then they got a poop transplant.

— The same exact foods affect each person’s gut bacteria differently.

But now, Rebyota is available as the first FDA-approved “fecal microbiota product.” In a late-stage clinical trial, the one-dose treatment reduced the rate of C. diff flare-ups by 29.4% in the eight weeks after antibiotic treatment, compared with a placebo, STAT reported. Taking two clinical trials of the treatment into account, the success rate of the treatment “was significantly higher in the Rebyota group (70.6%) than in the placebo group (57.5%),” the FDA noted.

Read more | >

On Nov. 16, Mayo Clinic in Arizona was able to celebrate a first in this practice and transplanted a heart into a patient following the natural circulatory death of the donor.

“Mayo Clinic is the only one in Arizona to have used this new ‘heart in a box’ technology,” the hospital said.

With this advancement, donors will be able to give the gift of life much sooner than before. Thousands of people are awaiting heart transplants and sadly, many do die while waiting.

Read more | >

“The risk of developing ALCL is actually much lower than the risk of experiencing a relapse of breast cancer,” says lead author Connor J. Kinslow, MD, a resident in radiation oncology at the Columbia University Vagelos College of Physicians and Surgeons.

“Based on our findings, we do not believe that women should be dissuaded from having implant-based breast reconstruction after mastectomy solely due to the risk of ALCL.”

The new study was designed to provide women with accurate information about risk and is the first to look at rates of ALCL in breast cancer survivors who’ve had breast implants after mastectomy.

Read more | >

“Our goal is to re-regulate all of your genes back to an earlier state.” Excellent. Hurry please. I’m 51.

Magnesium Break Through 10% Discount https://bit.ly/3O5tPfu.
This video brought to you by BiOptimizers.

In this video Dr Davidsohn discusses the next generation therapies that Rejuvenate Bio are working on. We also discuss, klotho, RJB02 and his personal protocol.

Dr Noah Davidsohn is a founder and Chief Scientific Officer of Rejuvenate Bio a company developing gene therapies to treat aging and age related diseases.

Rejuvenate Bio website.

Continue reading “Next Generation Therapies For Rejuvenation | Dr Noah Davidsohn Interview Series Ep5/5” | >

Tumors affecting the central nervous system (CNS), either primary or secondary, are highly prevalent and represent an unmet medical need. Prognosis of these tumors remains poor, mostly due to the low intrinsic chemo/radio-sensitivity of tumor cells, a meagerly known role of the microenvironment and the poor CNS bioavailability of most used anti-cancer agents. The BBTB is the main obstacle for anticancer drugs to achieve therapeutic concentrations in the tumor tissues. During the last decades, many efforts have been devoted to the identification of modalities allowing to increase drug delivery into brain tumors. Until recently, success has been modest, as few of these approaches reached clinical testing and even less gained regulatory approval.

Read more | >

They discovered that removing PLD3 from neurons using gene therapy resulted in a significant decrease in axonal swelling.

A study on Alzheimer’s published recently by Yale University is quite attention-grabbing. Because the disease’s crippling symptoms could be brought on by swelling in the brain brought on by amyloid plaques, say the experts.

One of the main features of Alzheimer’s is the formation of amyloid plaques. Researchers have been trying to shrink these plaques in their researchers for years. In addition, Yale researchers have found that swelling caused by a byproduct of these plaques may be the cause of the disease’s debilitating symptoms.

Read more | >